Login

Dr. Ian Walters, CEO, Portage Biotech Inc 00:00:00

Share On Facebook Share On Twitter

Portage’s Pipeline of Assets and What Makes Them Unique in the Immuno-Oncology Space

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Dr Romesh's Journey: From Bombay to Building Success in the U.S. | Dr Romesh Wadhwani, Co-Founder, Symphony Technology Group.
00:10:00
EGIF Q2 2024 Update with Ted Whitehead, Portfolio Manager at Arrow Capital Management Inc.
00:10:00
Apollo's Path to Dominance in Alternative Investments | Marc Rowan, CEO, Apollo Global Management.
00:10:00
Denison Mines Focuses on Advanced Uranium Development in Saskatchewan's Athabasca Basin
00:10:00
CEO and CFO Present FY Results Released on June 15 | Adam Vicary - Chief Executive Officer of Castings PLC
00:10:00
Managing Director at Harris Williams & Co. forecasts a significant transfer of value occurring over the next several years.
00:10:00
Port of New Orleans Celebrates 125 Years with Weekly Video Series
00:10:00
Provide sustainable cultivation of cannabis in greenhouses and sustainable production of activated carbon.|David Lesser, CEO,Millennium Investment Acquisition Company Inc
00:10:00
Maximizing the Value of Volunteer Time in Social Enterprises
00:10:00
investment firm that focuses on cross-border financial investment|Michael Nicklas,Managing Partner,Valor Capital Group
00:10:00
diverse founders leveraging financial innovation|Garnet S. Heraman,Managing Partner,Aperture Venture Capital
00:10:00
Empathetic Financial Planning: Tailored Strategies for Your Financial Dreams | Daniel Goodman, Director of Financial Planning and Wealth Advisor at Sierra Pacific Financial Advisors, LLC

© 2017 - Neuhu+